Centessa Pharmaceuticals-adr logo

Centessa Pharmaceuticals-adr share price today

(CNTA)

Centessa Pharmaceuticals-adr share price is $17.16 & ₹1,458.19 as on 21 Dec 2024, 2.30 'hrs' IST

$17.16

-0.39

(-2.22%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Centessa Pharmaceuticals-adr share price in Dollar and Rupees. Guide to invest in Centessa Pharmaceuticals-adr from India. Also see the sentimental analysis on Indian investors investing in Centessa Pharmaceuticals-adr. Get details on the Indian mutual funds that are investing in Centessa Pharmaceuticals-adr. Get Analyst recommendations and forecasts along with all the Centessa Pharmaceuticals-adr's financials.

Centessa Pharmaceuticals-adr share price movements

  • Today's Low: $16.94
    Today's High: $17.92

    Day's Volatility :5.47%

  • 52 Weeks Low: $6.65
    52 Weeks High: $18.97

    52 Weeks Volatility :64.94%

Centessa Pharmaceuticals-adr Returns

PeriodCentessa Pharmaceuticals-adrSector (Health Care)Index (Russel 2000)
3 Months
10.21%
-11.1%
0.0%
6 Months
93.03%
-6.0%
0.0%
1 Year
114.5%
2.7%
0.0%
3 Years
38.5%
0.6%
-19.7%

Centessa Pharmaceuticals-adr Key Statistics

in dollars & INR

Previous Close
$17.55
Open
$17.55
Today's High
$17.92
Today's Low
$16.94
Market Capitalization
$2.3B
Today's Volume
$774.8K
52 Week High
$18.97
52 Week Low
$6.65
Revenue TTM
$6.9M
EBITDA
$-161.3M
Earnings Per Share (EPS)
$-1.52
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-42.52%

How to invest in Centessa Pharmaceuticals-adr from India?

It is very easy for Indian residents to invest directly in Centessa Pharmaceuticals-adr from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Centessa Pharmaceuticals-adr stock in both Indian Rupees (INR) and US Dollars (USD). Search for Centessa Pharmaceuticals-adr or CNTA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Centessa Pharmaceuticals-adr or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Centessa Pharmaceuticals-adr shares which would translate to 0.050 fractional shares of Centessa Pharmaceuticals-adr as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Centessa Pharmaceuticals-adr, in just a few clicks!

Returns in Centessa Pharmaceuticals-adr for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Centessa Pharmaceuticals-adr investment value today

Current value as on today

₹2,16,696

Returns

₹1,16,696

(+116.7%)

Returns from Centessa Pharmaceuticals-adr Stock

₹1,14,500 (+114.5%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Centessa Pharmaceuticals-adr

2950.0%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Investment in Centessa Pharmaceuticals-adr from India has grown in the last 30 days as on Dec 21, 2024. 2950.0% more purchase transactions for Centessa Pharmaceuticals-adr in the last 30 days versus the previous period.

1410%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Centessa Pharmaceuticals-adr on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 1410% more investors are searching Centessa Pharmaceuticals-adr in the last 30 days versus the previous period.

Global Institutional Holdings in Centessa Pharmaceuticals-adr

  • Medicxi Ventures Management (Jersey) Ltd

    15.14%

  • General Atlantic Llc

    7.34%

  • Perceptive Advisors LLC

    4.76%

  • First Light Asset Management, LLC

    4.51%

  • T. Rowe Price Associates, Inc.

    3.55%

  • Adage Capital Partners Gp LLC

    3.18%

Analyst Recommendation on Centessa Pharmaceuticals-adr

Buy

    81%Buy

    18%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Centessa Pharmaceuticals-adr(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Centessa Pharmaceuticals-adr

What analysts predicted

Upside of 66.5%

Current:

$17.16

Target:

$28.57

Insights on Centessa Pharmaceuticals-adr

  • Price Movement

    In the last 7 days, CNTA stock has moved up by 3.6%

Centessa Pharmaceuticals-adr Technicals Summary

Sell

Neutral

Buy

Centessa Pharmaceuticals-adr is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Centessa Pharmaceuticals-adr Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Centessa Pharmaceuticals-adr
-5.66%
93.03%
114.5%
38.5%
-21.75%
Regeneron Pharmaceuticals, Inc.
-5.73%
-34.03%
-17.11%
13.66%
87.56%
Biontech Se
4.48%
30.56%
7.36%
-56.46%
225.6%
Alnylam Pharmaceuticals, Inc.
-0.55%
10.11%
28.49%
30.99%
109.19%
Vertex Pharmaceuticals Incorporated
-11.79%
-16.36%
-1.97%
78.33%
80.59%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Centessa Pharmaceuticals-adr
NA
NA
NA
-1.44
-0.43
-0.2
NA
4.29
Regeneron Pharmaceuticals, Inc.
17.51
17.51
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.17
0.55
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Centessa Pharmaceuticals-adr
Buy
$2.3B
-21.75%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$77.8B
87.56%
17.51
33.61%
Biontech Se
Buy
$26.7B
225.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.8B
109.19%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$102.1B
80.59%
32.84
-4.51%

About Centessa Pharmaceuticals-adr

centessa pharmaceuticals plc is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process. the company applies an asset-centric r&d model at scale to advance a portfolio of highly validated programs led by industry leading teams. each program is developed by a centessa subsidiary and supported by a centralized infrastructure and the centessa management team. the company is headquartered in cambridge, mass.
Organization
Centessa Pharmaceuticals-adr
Employees
76
CEO
Dr. Saurabh Saha M.D., Ph.D.
Industry
Healthcare

Management People of Centessa Pharmaceuticals-adr

NameTitle
Dr. Saurabh Saha M.D., Ph.D.
CEO & Director
Dr. David M. Chao Ph.D.
Chief Administrative Officer
Mr. John J. Crowley CPA
CFO and Principal Financial & Accounting Officer
Ms. Tia L. Bush
Chief Technology & Quality Officer
Ms. Kristen K. Sheppard Esq., J.D.
Senior Vice President of Investor Relations & Corporate Communications
Mr. Iqbal J. Hussain L.L.B.
General Counsel, Chief Compliance Officer & Corporate Secretary
Ms. Karen M. Anderson
Chief People Officer
Dr. Gregory M. Weinhoff M.B.A., M.D.
Chief Business Officer
Dr. Mario Alberto Accardi Ph.D.
President of the Orexin Program
Dr. Ellie Im M.D.
Senior Vice President of Clinical Development & Oncology

Important FAQs about investing in Centessa Pharmaceuticals-adr from India :

What is Centessa Pharmaceuticals-adr share price today?

Centessa Pharmaceuticals-adr share price today stands at $17.16, Open: $17.55 ; Previous Close: $17.55 ; High: $17.92 ; Low: $16.94 ; 52 Week High: $18.97 ; 52 Week Low: $6.65. The stock opens at $17.55, after a previous close of $17.55. The stock reached a daily high of $17.92 and a low of $16.94, with a 52-week high of $18.97 and a 52-week low of $6.65.

Can Indians buy Centessa Pharmaceuticals-adr shares?

Yes, Indians can invest in the Centessa Pharmaceuticals-adr (CNTA) from India.

With INDmoney, you can buy Centessa Pharmaceuticals-adr at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Centessa Pharmaceuticals-adr at zero transaction cost.

How can I buy Centessa Pharmaceuticals-adr shares from India?

It is very easy to buy Centessa Pharmaceuticals-adr from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Centessa Pharmaceuticals-adr be purchased?

Yes, you can buy fractional shares of Centessa Pharmaceuticals-adr with INDmoney app.

What are the documents required to start investing in Centessa Pharmaceuticals-adr stocks?

To start investing in Centessa Pharmaceuticals-adr, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Centessa Pharmaceuticals-adr

Today’s highest price of Centessa Pharmaceuticals-adr (CNTA) is $17.92.

Today’s lowest price of Centessa Pharmaceuticals-adr (CNTA) is $16.94.

What is today's market capitalisation of Centessa Pharmaceuticals-adr

Today's market capitalisation of Centessa Pharmaceuticals-adr CNTA is 2.3B

What is the 52 Week High and Low Range of Centessa Pharmaceuticals-adr

  • 52 Week High

    $18.97

  • 52 Week Low

    $6.65

What are the historical returns of Centessa Pharmaceuticals-adr?

  • 1 Month Returns

    -5.66%

  • 3 Months Returns

    93.03%

  • 1 Year Returns

    114.5%

  • 5 Years Returns

    -21.75%

Who is the Chief Executive Officer (CEO) of Centessa Pharmaceuticals-adr

Dr. Saurabh Saha M.D., Ph.D. is the current Chief Executive Officer (CEO) of Centessa Pharmaceuticals-adr.